63 results
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
-twenties
Enhances Norgine’s commitment to bringing transformative therapies to patients in Europe, U.K., Australia, and New Zealand who currently do … . Commitment to transforming people’s lives drives everything Norgine does with fully integrated infrastructure and exceptional partnership approach
424B7
FENC
Fennec Pharmaceuticals Inc
15 Mar 24
Prospectus with selling stockholder info
3:53pm
as payment of our commitment fee under the SPA. The Warrants grant the selling stockholder the right to purchase up to 110,996 shares of our common shares … transactions;
through broker/dealers, who may act as agents or principals;
through one or more underwriters on a firm commitment or best-efforts basis
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
of Investor
Principal Amount
of First Closing
Note
Aggregate First
Closing
Purchase Price
First
Commitment
Fee Warrants
Second
Commitment
Fee Warrants
8-K/A
EX-99.1
o1v4oe74
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-99.1
fsl 8lkl3b2tkqn
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
hyf6dfh7 o184
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am
8-K
mh3 uqh6ndc5
26 Sep 22
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment
5:03pm
8-K
ba7t b5j8rgd8dy
22 Aug 22
Fennec Pharmaceuticals Closes First $5 Million Investment
9:00am
8-K
8lfh3d0r4czs 5bk3lx
1 Aug 22
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
4:15pm